Cough suppressant may treat dyskinesias in Parkinson’s patientsNovember 14th, 2007 - 10:16 am ICT by admin
The researchers also found that BMY-14802, a drug previously tested in people with schizophrenia and found to be safe, although not effective in treating schizophrenia symptoms, suppressed dyskinesias in rats more effectively than dextromethorphan did, suggesting that BMY-14802 might work to block dyskinesias in people with Parkinson’s.
Dyskinesias are the spastic or repetitive motions that result from taking levodopa, or L-dopa, over long periods.
“These results were unexpected, but very exciting. We have filed a patent for the use of BMY-14802 for dyskinesias and we hope to get funding to begin human trials very soon,” Paquette said.
The findings also stated the value of the rat model for dyskinesias that was used in the study.
Previous studies have shown that the drug amantadine was effective in treating dyskinesias in both humans and rats.
“Basically, these two drugs work to block dyskinesias in both humans and rats, and that means the rats are a good model to screen potential drug treatments for humans with dyskinesias,” Paquette said.
But BMY-14802, which is an antagonist at sigma-1 receptor sites in the brain, “worked much better than dextromethorphan,” an antagonist at N-methyl-D-aspartate (NMDA) receptors.
“There’s something special about BMY-14802. The effect on dyskinesias is really striking and I’ve repeated it several times, so it’s a reliable finding. It’s a very exciting result,” Paquette said. (ANI)
- Rave drug sparks hope for treating Parkinson's - Jun 15, 2012
- New brain imaging technique shows effects of Parkinson's drug - Dec 01, 2010
- Soon, drugs that could treat cocaine addiction - Aug 11, 2010
- Obesity a factor in how kids metabolize drugs - Apr 28, 2010
- New study could lead to potential drug targets for schizophrenia, Parkinson's - Mar 12, 2011
- Brain parasite affects reward producing chemical - Nov 06, 2011
- Biological reason behind why depression hits women more than men - Jun 16, 2010
- New research paves way for better Graves' disease treatment - Dec 02, 2010
- Acid suppressive drugs may increase pneumonia risk - Dec 21, 2010
- Scientists use zebrafish to study Parkinson's disease - Apr 23, 2010
- Brain chemical that regulates mood may have anti-diabetic properties - Nov 14, 2010
- What causes brain cell death in Parkinson's patients - Jan 08, 2011
- Conventional theory of modern drug design challenged - Oct 11, 2010
- Scientists produce compound that may treat Parkinson's disease - Feb 12, 2011
- Naturally occurring brain mechanism ups Parkinson's understanding - Feb 12, 2011
Tags: amantadine, antagonist, bmy, cough suppressant, dextromethorphan, dyskinesias, flu medications, l dopa, levodopa, nmda receptors, ohsu school, paquette, parkinson, rat model, rats, robitussin, schizophrenia symptoms, sucrets, treating schizophrenia, triaminic